Hjem › Multipelt myelom › California › Orange
Kliniske studier for Multipelt myelom i Orange, CA
9 studier for Multipelt myelom søker deltakere på steder i og rundt Orange (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- University of California Irvine Medical Center, Orange
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
- UC Irvine, Orange
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
RekruttererFase 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
RekruttererFase 3
- Chao Family Comprehensive Cancer Center UCI, Orange
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- UC Irvine Health, Orange
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruttererFase 3
- Research Site, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RekruttererFase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
RekruttererFase 4
- UC Irvine Health, Orange
- UCI Health, Orange
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
RekruttererFase 1/2
- UC Irvine Health, Orange
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Orange
- Ikke-småcellet lungekreft25 studier
- Metastatisk kreft20 studier
- Kolorektal kreft16 studier
- Eggstokkreft16 studier
- Pankreaskreft15 studier
- Brystkreft14 studier
- Lungekreft14 studier
- Prostatakreft14 studier
- Leverkreft (hepatocellulært karcinom)14 studier
- Melanom14 studier
- Akut myelogen leukemi13 studier
- Kreft (alle typer)13 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.